Key Highlights
- $3M Seed Round: Backing from AZ Crown, Mayo Clinic, and Insight Enterprises Inc.’s Eric Crown.
- Revolutionizing Motion Perception: VMocion’s 3V™ technology offers a virtually stimulated physical motion sense, enhancing VR/AR/XR experiences.
- Combatting Motion Sickness: WAIV™ technology mitigates motion sickness, expanding access and comfort in immersive experiences.
Source: PR Newswire
Notable Quote
No quotes were given.
SoH's Take
The strategic infusion of $3M seed capital into VMocion’s innovative 3V™ and WAIV™ technologies marks a significant milestone in the entertainment technology landscape. By addressing the long-standing issue of motion sickness and enhancing user engagement in VR, AR, and XR, VMocion not only broadens the accessibility of immersive experiences but also paves the way for substantial advancements in various sectors, including gaming, transportation, and training. Their collaboration with esteemed institutions like the Mayo Clinic underscores the technology’s credibility and potential. As industries continue to embrace immersive technologies, VMocion’s developments could be at the forefront of this transformative wave.
Related

Morf Raises $3M in Seed Funding to Revolutionize Healthcare Administration
Key Highlights Morf secures $3M seed round, led by Kindred Ventures, with Uncommon Capital and Asymmetric Capital Partners participating.The platform enables healthcare providers to streamline administrative tasks, focusing on patient care rather than on cumbersome manual processes.Founders Montana Scher and James Thompson bring over 20 years of software and data product expertise from…

RxDiet Secures $3M Seed Funding to Expand Food as Medicine Programs
Key Highlights $3M seed funding led by Giant Ventures.Partnerships with 2 of the 3 largest US health insurers.97 NPS score in Aetna programs.Plans to launch a low-cost digital tool this year.AI-driven personalized meal plans for chronic illnesses.Source: Business Wire Notable Quotes “Using food to treat chronic conditions is often cost-prohibitive,…

Novanta Acquires Motion Solutions: Expanding Presence in Medical and Precision Medicine Markets
Key Highlights Novanta Inc. enters a definitive agreement to acquire Motion Solutions for $189 million, enhancing its technology offerings in medical and precision medicine sectors.Motion Solutions, renowned for engineering high-precision subsystems, will bring advanced motion control solutions to Novanta’s product portfolio.The acquisition is expected to generate approximately $85 million in revenue in 2023, financed through cash and…